Table 1.
Aβ Species | Properties | Study Models | Refs. |
---|---|---|---|
Amyloid fibrils | Stable and filamentous Aβ aggregates with fibrillar structure and common structural features | In vitro; patients with AD; mouse models | [34-36] |
Aβ protofibrils | Flexible, short, rod-like structure; <200 nm in length; 6-8 nm in diameter; toxic; precursor of mature fibrils |
In vitro | [37-40] |
Aβ Plaques | Mainly composed of fibrils; not toxic; large extracellular Aβ deposits; surrounded by reactive astrocytes, activated microglia, axons, and dystrophic dendrites |
In vivo; patients with AD; mouse models | [41, 42] |
Aβ derived diffusible ligands (ADDLs) | Neurotoxic; nonfibrillar; an estimated mass of 17-42 kDa; trimers to 24 mers | In vitro; brain extracts of humans and murine models | [43, 44] |
Small oligomers | Toxic; mostly unstable and transient; comprised of 3-50 monomers; heteromorphous | In vivo; AD individuals; mouse models | [6, 9, 45-48] |
Annular Aβ oligomers | Play significant roles in membrane-disrupting ion channels or pores |
In vitro; cell culture | [49-53] |
Aβ Monomers | Mainly α-helical and random coil in structure; produced from APP; soluble amphipathic molecule | In vitro; in vivo; human brain extracts | [54-56] |
Aβ Dimers | Diameter of around 35 nm; hydrophobic core | In vitro; in vivo; human brain extracts | [57-59] |
Aβ Trimers | Act as a subunit of toxic oligomers | In vivo; mouse models | [6, 60] |